supp.fit

Hops: study protocols

28 study groups say how much Hops participants took a day. These are the doses the studies gave. They are not a recommendation.

Hops: what the research found →

Dose per serving from products

190 products in our catalogue print how much Hops a serving holds.

Most common: 25 mg to 50 mg, 24% of 190 products.

Dose per servingProducts
2.5 mg or less
2
2.5 mg to 5 mg
14
5 mg to 10 mg
4
10 mg to 25 mg
25
25 mg to 50 mg
45
50 mg to 100 mg
34
100 mg to 250 mg
34
250 mg to 500 mg
24
over 500 mg
8

Dose per serving from research

26 study groups in 20 studies say how much Hops participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg and 250 mg to 500 mg, 27% of 26 study groups each.

Daily doseStudy groups
100 mcg or less
2
100 mcg to 250 mcg
2
250 mcg to 500 mcg
0
500 mcg to 1 mg
0
1 mg to 2.5 mg
0
2.5 mg to 5 mg
0
5 mg to 10 mg
0
10 mg to 25 mg
4
25 mg to 50 mg
7
50 mg to 100 mg
0
100 mg to 250 mg
4
250 mg to 500 mg
7

Commonly used together

7 of 28 study groups took Hops with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Valerian
4

28 study groups

Study
Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients
2023 · Group Xn · Adults aged 22–83 with severe COVID-19 and acute respiratory failure admitted to the ICU
4.5 mg/kg7 days25
Matured hop extract reduces body fat in healthy overweight humans: a randomized, double-blind, placebo-controlled parallel group study
2016 · Active group · Men and women aged 20 to under 65 years with BMI 25 to under 30 kg/m²
35 mg12 weeks100
The relationship between the effect of matured hop extract and physical activity on reducing body fat: re-analysis of data from a randomized, double-blind, placebo-controlled parallel group study
2018 · active group · Men and women aged 20–65 years with BMI 25–30 kg/m²
35 mg12 weeks91
Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline
2020 · MHBA group · Adults aged 45–69 years with subjective cognitive decline
35 mg12 weeks49
A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts
2010 · active treatment (hop extract) · Menopausal women; age range and condition details beyond menopausal discomforts not reported
100 mcg8 weeks36
Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized, placebo-controlled, double-blind, crossover pilot study
2017 · Melcalin hops · Apparently healthy young adults aged about 25 years reporting at least mild depression, anxiety and stress symptoms; 31 females and 5 males completed the study
200 mg4 weeks36
New Zealand Bitter Hops Extract Reduces Hunger During a 24 h Water Only Fast
2019 · high dose (HD) · Healthy lean men; participants were 18–40 years old, with BMI 20–24.9 kg/m².
500 mg1 day30
New Zealand Bitter Hops Extract Reduces Hunger During a 24 h Water Only Fast
2019 · low dose (LD) · Healthy lean men; participants were 18–40 years old, with BMI 20–24.9 kg/m².
200 mg1 day30
An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial
2022 · Quick-release capsules (gastric) · Healthy-weight men
500 mg1 day19
An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial
2022 · Delayed-release capsules (duodenal) · Healthy-weight men
500 mg1 day19
A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts
2006 · 100 microg 8-PN hop extract group · Menopausal women; age range and menopausal condition details not reported
100 mcg12 weeks—
A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts
2006 · 250 microg 8-PN hop extract group · Menopausal women; age range and menopausal condition details not reported
250 mcg12 weeks—
Hop polyphenols suppress production of water-insoluble glucan by Streptococcus mutans and dental plaque growth in vivo
2008 · High-dosage group · Healthy subjects; age and sex not reported
140 mg3 days—
Hop polyphenols suppress production of water-insoluble glucan by Streptococcus mutans and dental plaque growth in vivo
2008 · Low-dosage group · Healthy subjects; age and sex not reported
49 mg3 days—
Effects of Hop Bitter Acids, Bitter Components in Beer, on Cognition in Healthy Adults: A Randomized Controlled Trial
2020 · MHBAs-treated group · Healthy adults aged 45–64 years with self-awareness of cognitive decline
35 mg12 weeks—
Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial
2005 · valerian-hops combination · Adults with mild insomnia; mean age 44.3 years; 110 women and 74 men across the study
41.9 mg4 weeks59
Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial
2013 · NSF-3 group · Adults of either sex diagnosed with primary insomnia
30 mg2 weeks39
Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms
2008 · verum · Poor sleepers identified by the validated sleep questionnaire SF-B; age and sex not reported
2 mL1 day20
Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial
2025 · Ze 91019 · Healthy men and women aged 18–65 with occasional sleep problems and subjective cognitive difficulties, without diagnosed insomnia
120 mg3 weeks18
Rice Protein Matrix Enhances Circulating Levels of Xanthohumol Following Acute Oral Intake of Spent Hops in Humans
2018 · spent hops-rice protein matrix preparation · Healthy participants; age and sex not specified
12.4 mg1 day6
Rice Protein Matrix Enhances Circulating Levels of Xanthohumol Following Acute Oral Intake of Spent Hops in Humans
2018 · control spent hops preparation · Healthy participants; age and sex not specified
12.4 mg1 day6
Impact of xanthohumol (a prenylated flavonoid from hops) on DNA stability and other health-related biochemical parameters: Results of human intervention trials
2016 · XN drink · Participants; age, sex, and health condition not reported
12 mg—22
The Oral Bioavailability of 8-Prenylnaringenin from Hops (Humulus Lupulus L.) in Healthy Women and Men is Significantly Higher than that of its Positional Isomer 6-Prenylnaringenin in a Randomized Crossover Trial
2018 · 6-PN · Healthy women and men; ages not stated
500 mg1 day16
The Oral Bioavailability of 8-Prenylnaringenin from Hops (Humulus Lupulus L.) in Healthy Women and Men is Significantly Higher than that of its Positional Isomer 6-Prenylnaringenin in a Randomized Crossover Trial
2018 · 8-PN · Healthy women and men; ages not stated
500 mg1 day16
A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women
2022 · XN-rich hop extract · Healthy, normal-weight women; age not stated
125 mcg1 day9
Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial
2021 · xanthohumol · Adults aged 21–50 years who were healthy, without stated chronic disease
24 mg8 weeks16
Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome
2011 · intervention arm · Postmenopausal women with metabolic syndrome
400 mg14 weeks25
Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial
2010 · treatment arm · Healthy postmenopausal women
400 mg14 weeks16